文献速递主动脉疾病

胸主动脉腔内修复术治疗逆行性A型主动脉夹层

Thoracic endovascular aortic repair for retrograde type A aortic dissection.
PubMed 文献 · J Vasc Surg · 2019-01-03

本研究回顾性分析了31例因逆行性A型主动脉夹层(r-TAAD)接受胸主动脉腔内修复术(TEVAR)的患者,发现TEVAR在生存方面有前景,但术后主动脉相关不良事件发生率不容忽视,需谨慎选择患者并密切随访。

要点

  • TEVAR治疗r-TAAD的1年、5年、10年总生存率分别为97%、93%、80%。
  • 早期主动脉相关不良事件发生率为26%,晚期为23%,均需额外干预。
  • 术后主动脉相关无事件生存率1年、5年、10年分别为58%、58%、51%。

核心结论

  • TEVAR治疗r-TAAD在生存方面似乎有前景,但术后主动脉相关不良事件发生率不容忽视。
  • 仔细选择患者很重要,且TEVAR后必须密切随访以避免灾难性后果。

研究设计与样本

  • 回顾性综述了1997年5月至2016年1月在三家机构接受TEVAR治疗的31例r-TAAD患者的医疗记录。
  • 患者平均年龄64±11岁,其中30例男性,1例女性。

主要发现

  • 所有患者入口撕裂均位于降胸主动脉。
  • 7例(23%)存在夹层相关并发症;升主动脉假腔通畅13例(42%),血栓形成18例(58%)。
  • 升主动脉最大直径为45±4 mm。
  • TEVAR在急性期进行24例(77%),亚急性期7例(23%)。
  • 仅1例(3%)在TEVAR后30天内死于主动脉破裂。

临床怎么用

  • TEVAR可用于r-TAAD的治疗,但需严格选择患者。
  • 术后应密切随访以监测主动脉相关不良事件。

局限性

  • 回顾性研究,样本量较小(31例)。
  • 来自三家机构,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The efficacy of thoracic endovascular aortic repair (TEVAR) for retrograde type A aortic dissection (r-TAAD) with the entry tear in the descending aorta has not been clarified. METHODS: The medical records of 31 patients who underwent TEVAR for r-TAAD at three institutions between May 1997 and January 2016 were retrospectively reviewed. RESULTS: The mean age of the patients (30 men and 1 woman) was 64 ± 11 years. The entry tear was located in the descending thoracic aorta in all patients. Seven patients (23%) had dissection-related complications. The false lumen of the ascending aorta was patent in 13 patients (42%) and thrombosed in 18 (58%). The maximum diameter of the ascending aorta was 45 ± 4 mm. TEVAR was performed in the acute phase in 24 patients (77%) and in the subacute phase in 7 (23%). Only one patient (3%) died of aortic rupture within 30 days after TEVAR. Early aorta-related adverse events were observed in eight patients (26%), of whom five underwent additional interventions. The mean follow-up period was 99 ± 69 months. There were no late aorta-related deaths, although five patients died of other causes during follow-up. Overall survival rates at 1 year, 5 years, and 10 years were 97%, 93%, and 80%, respectively. Late aorta-related adverse events were observed in seven patients (23%), of whom five underwent additional interventions. Aorta-related event-free survival rates at 1 year, 5 years, and 10 years were 58%, 58%, and 51%, respectively. CONCLUSIONS: TEVAR for r-TAAD seems promising in terms of survival. However, the incidence of postoperative aorta-related adverse events is not negligible, so careful selection of patients is important. In addition, close follow-up is mandatory after TEVAR to avoid catastrophic consequences.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Higashigawa T, Kato N, Nakajima K, et al. Thoracic endovascular aortic repair for retrograde type A aortic dissection. J Vasc Surg. 2019. PMID: 30612823. doi:10.1016/j.jvs.2018.08.193

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。